Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 68
- Registration Number
- NCT00779376
- Locations
- 🇨🇦
MDS Pharma Services, Montreal, Quebec, Canada
Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 36
- Registration Number
- NCT00779831
- Locations
- 🇨🇦
MDS Pharma Services, Saint-Laurent, Quebec, Canada
Bioequivalence Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fed Conditions
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 36
- Registration Number
- NCT00780013
- Locations
- 🇨🇦
MDS Pharma Services, Saint-Laurent, Quebec, Canada
Bioequivalence Study of Pseudoephedrine HCl 120 mg ER Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00779805
- Locations
- 🇮🇳
Ranbaxy CPU, Gurgaon, Haryana, India
Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT00779233
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Las Vegas, Nevada, United States
Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 36
- Registration Number
- NCT00779350
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburgh, Pennsylvania, United States
Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-10-24
- Last Posted Date
- 2008-10-24
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 36
- Registration Number
- NCT00779051
- Locations
- 🇺🇸
PRACS Institute Ltd., Fargo, North Dakota, United States
Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg - 42.9 mg/ 5 mL Oral Suspension Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Drug: Amoxicillin-Clavulanic acid 600mg - 42.9 mg/ 5 mL oral suspension
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 48
- Registration Number
- NCT00778414
- Locations
- 🇨🇦
Anapharm, Quebec, Canada
Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT00778427
- Locations
- 🇺🇸
NovumPharmaceutical Research Services, Las Vegas, Nevada, United States
Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2009-12-15
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 36
- Registration Number
- NCT00778024
- Locations
- 🇺🇸
Gateway medical research, St. Charles, Missouri, United States